Ceribell, Inc. (CBLL)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $27.22
- As of
Kresmion compiles this page from CBLL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Ceribell, Inc. (CBLL): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-10.
See the full CBLL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CBLL on one page. Preview it with sample data, then open it live with a free account.
Preview the CBLL dossierActive events for CBLL
- mediumEarnings below estimates
Q2-2026: Missed consensus by 6.1%, EPS $-0.51 vs $-0.4807 estimate
- high13F: large increase
D. E. Shaw & Co., Inc. added +76% to CBLL (2026Q2)
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 66% of CBLL (2026Q2)
- high13F: funds added
3 tracked funds increased CBLL this 2026Q1 - institutional consensus
- high13F: large increase
Point72 Asset Management, L.P. added +2174% to CBLL (2026Q1)
FREE, NO ACCOUNT
Every event on CBLL, as it fires
You are seeing 5 of 11 events recorded on CBLL since 2026-05-29.
The five above landed across 3 days. The other 6 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CBLL (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 15678C102 · 2026Q2 | $14.1M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 15678C102 · 2026Q2 | $3.8M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 15678C102 · 2026Q2 | $2.9M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 15678C102 · 2026Q2 | $2.1M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 15678C102 · 2026Q2 | $1.9M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CBLL
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CBLL against its peers
CBLL's operating margin of -65.6% ranks in the 17th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | CBLL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 89.1M USD | 283M USD | 21 | 20 |
| Gross margin | 87.9% | 64.4% | 98 | 19 |
| Operating margin | -65.6% | -16.5% | 17 | 20 |
| Net margin | -60.0% | -14.0% | 17 | 20 |
| Return on equity | -34.4% | -11.4% | 33 | 19 |
| P / E | n/a | 32.7x | n/a | 5 |
Peers (20): BBNX, AORT, SIBN, QDEL, IART, AVNS.D, ENOV, INMD, KIDS, TCMD, ESTA, BFLY, DCTH, UFPT, SSII, MASS, RCEL, NPCE, NEOG, OFIX. Left out: LMRI (no annual filing), NHNKF (no annual filing), OSSUY (no annual filing), ALMR (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (CBLL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CBLL on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CBLL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.